SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,354.81 |
| Enterprise Value ($M) | 1,466.25 |
| Book Value ($M) | 173.29 |
| Book Value / Share | 0.73 |
| Price / Book | 7.82 |
| NCAV ($M) | 99.40 |
| NCAV / Share | 0.42 |
| Price / NCAV | 13.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.13 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.07 |
| Current Ratio | 5.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 361.87 |
| Assets | 435.75 |
| Liabilities | 262.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 333.62 |
| Operating Income | -27.95 |
| Net Income | -39.14 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -44.81 |
| Cash from Investing | -18.32 |
| Cash from Financing | 106.59 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | |||
| 13G | State Street Corp | |||
| 13G | Vanguard Group Inc | 5.61 | ||
| 13G/A | Millennium Management Llc | 0.00 | -99.94 | |
| 13G | BlackRock, Inc. | 7.20 | 198.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,239,618 | 6,284,201 | 19.73 | |
| 808,302 | 5,722,311 | 14.13 | |
| 1,064,125 | 4,280,108 | 24.86 | |
| 779,987 | 4,463,183 | 17.48 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLT – Applied Therapeutics, Inc. | AQST – Aquestive Therapeutics, Inc. |
| ARCT – Arcturus Therapeutics Holdings Inc. | ATAI – Atai Life Sciences N.V. |
| ATXS – Astria Therapeutics, Inc. |